PROCEPT BioRobotics Corp
Closed
SectorHealthcare
25.8 -6.66
Overview
Share price change
24h
Min
25.19
Max
25.95
Income | -1.8M -32M |
|---|---|
Sales | 6.7M 83M |
EPS | -0.56 |
Profit margin | -38.058 |
Employees | 888 |
EBITDA | -9.1M -31M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +16.73% upside |
Next Earnings | 5 sie 2026 |
|---|
Market Cap | 250M 1.6B |
|---|---|
Previous open | 32.46 |
Previous close | 25.8 |
News Sentiment
By Acuity
43%
57%
118 / 342 Ranking in Healthcare
PROCEPT BioRobotics Corp Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
About PROCEPT BioRobotics Corp
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
